{"id":10445,"date":"2024-10-09T10:35:45","date_gmt":"2024-10-09T07:35:45","guid":{"rendered":"https:\/\/ozgurkilickesmez.com\/?p=10445"},"modified":"2026-10-13T22:22:02","modified_gmt":"2026-10-13T19:22:02","slug":"hifu-in-prostate-cancer","status":"publish","type":"post","link":"https:\/\/ozgurkilickesmez.com\/en\/hifu-in-prostate-cancer\/","title":{"rendered":"HIFU for Prostate Cancer: Procedure, Benefits, Risks and Recovery"},"content":{"rendered":"

HIFU (High-Intensity Focused Ultrasound) in prostate cancer is a non-invasive treatment that uses focused ultrasound waves to destroy malignant tissue through thermal energy. It provides a precise and organ-sparing therapy option.<\/span><\/p>\n

The procedure is performed under imaging guidance, ensuring accurate targeting of cancerous areas while minimizing damage to surrounding healthy prostate tissue. It is often considered for localized prostate cancer cases.<\/span><\/p>\n

HIFU offers benefits such as reduced recovery time, minimal complications, and the possibility of retreatment if necessary. It is particularly suitable for patients who wish to avoid radical prostate surgery.<\/span><\/p>\n

Indications include localized, organ-confined prostate cancer or recurrence after radiation therapy. Long-term studies demonstrate its effectiveness in disease control and quality-of-life preservation.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Treatment Method<\/td>\nHigh\u2011Intensity Focused Ultrasound (HIFU)<\/td>\n<\/tr>\n
Definition<\/td>\nA minimally invasive treatment for prostate cancer that uses focused high\u2011intensity ultrasound waves to heat and destroy cancerous cells.<\/td>\n<\/tr>\n
Applications<\/td>\nEarly\u2011stage, localized prostate cancer; suitable for patients ineligible for or declining surgery or radiotherapy.<\/td>\n<\/tr>\n
Advantages<\/td>\nTargets cancer cells with minimal damage to surrounding healthy tissue; lower risk of urinary and sexual side effects compared to other treatments.<\/td>\n<\/tr>\n
Procedure<\/td>\nUnder spinal or general anesthesia, a transrectal ultrasound probe is used to focus on the tumor area; ultrasound waves raise the temperature of cancerous tissue, causing cell death. The procedure typically lasts 1\u20133 hours.<\/td>\n<\/tr>\n
Side Effects<\/td>\nTemporary difficulty urinating, urinary tract infection, urinary incontinence, rare rectal pain or burns; serious complications are uncommon.<\/td>\n<\/tr>\n
Success Rate<\/td>\nHigh success rate in localized, early\u2011stage tumors; varies based on tumor size and location.<\/td>\n<\/tr>\n
Follow\u2011Up<\/td>\nRegular monitoring of prostate\u2011specific antigen (PSA) levels post\u2011procedure, with MRI or biopsy as needed.<\/td>\n<\/tr>\n
Alternative Methods<\/td>\nRadical prostatectomy, radiotherapy, irreversible electroporation (NanoKnife), cryotherapy.<\/td>\n<\/tr>\n
Related Conditions<\/td>\nProstate cancer, localized low\u2011 and intermediate\u2011risk prostate tumors.<\/td>\n<\/tr>\n
Precautions<\/td>\nPre\u2011procedure antibiotics recommended to reduce infection risk; PSA and MRI results guide treatment planning.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\t
\n\t\t
\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t
\n\t\t\t\n\n
\n\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n\n
\n\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n\n\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\"Interventional\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n